Abstract

Bradykinesia is a well-documented DOPA-responsive clinical feature of Parkinson’s disease (PD). While amplitude deficits (hypokinesia) are a key component of this slowness, it is important to consider how dopamine influences both the amplitude (hypokinesia) and frequency components of bradykinesia when a bimanually coordinated movement is required. Based on the notion that the basal ganglia are associated with sensory deficits, the influence of dopaminergic replacement on sensory feedback conditions during bimanual coordination was also evaluated. Bimanual movements were examined in PD and healthy comparisons in an unconstrained three-dimensional coordination task. PD were tested “off” (overnight withdrawal of dopaminergic treatment) and “on” (peak dose of dopaminergic treatment), while the healthy group was evaluated for practice effects across two sessions. Required cycle frequency (increased within each trial from 0.75 to 2 Hz), type of visual feedback (no vision, normal vision, and augmented vision), and coordination pattern (symmetrical in-phase and non-symmetrical anti-phase) were all manipulated. Overall, coordination (mean accuracy and standard deviation of relative phase) and amplitude deficits during bimanual coordination were confirmed in PD participants. In addition, significant correlations were identified between severity of motor symptoms as well as bradykinesia to greater coordination deficits (accuracy and stability) in PD “off” group. However, even though amplitude deficits (hypokinesia) improved with dopaminergic replacement, it did not improve bimanual coordination performance (accuracy or stability) in PD patients from “off” to “on.” Interestingly, while coordination performance in both groups suffered in the augmented vision condition, the amplitude of the more affected limb of PD was notably influenced. It can be concluded that DOPA-responsive hypokinesia contributes to, but is not directly responsible for bimanual coordination impairments in PD. It is likely that bimanual coordination deficits in PD are caused by the combination of dopaminergic system dysfunction as well as other neural impairments that may be DOPA-resistant or related to non-dopaminergic pathways.

Highlights

  • Bradykinesia is a well-documented clinical feature of Parkinson’s disease (PD) that is characterized by progressive reduced frequency and/or amplitude of movements [1, 2]

  • Student’s t -tests revealed that there were no significant differences between PD and healthy comparison participants when considering age, self-reported education, amount of time between sessions and 3-MS scores

  • A significant correlation was revealed between the severity of motor symptoms in PD “off ” participants and the mean coordination accuracy across all conditions

Read more

Summary

Introduction

Bradykinesia is a well-documented clinical feature of Parkinson’s disease (PD) that is characterized by progressive reduced frequency and/or amplitude (hypokinesia) of movements [1, 2]. Bradykinesia responds well to dopamine replacement [2, 3], with amplitude (hypokinesia) being a key contributor to these improvements [4]. The presence of bimanual coordination deficits in individuals with PD supports the notion that the basal ganglia contribute to the execution of coordinated movements. Based on these previous studies, it is plausible that bimanual coordination deficits in individuals with PD may be caused by amplitude and/or frequency deficits. If this were the case, one might predict that dopaminergic replacement therapy in individuals with www.frontiersin.org

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call